Résumé
Tumors are often polyclonal and are therefore heterogenous in their genomic and molecular profiles, which contributes to drug resistance and treatment failure. The methods used to detect these heterogenous differences in tumor samples are critical, but findings have been hindered by methodological inability to detect low-frequency subclones in bulk DNA. Chang et al. (2020) have addressed some of these methodological issues.
| langue originale | English |
|---|---|
| Pages (de - à) | 1501-1503 |
| Nombre de pages | 3 |
| journal | Journal of Investigative Dermatology |
| Volume | 140 |
| Numéro de publication | 8 |
| Date de mise en ligne précoce | 21 juil. 2020 |
| Les DOIs |
|
| état | Published - 1 août 2020 |
SDG des Nations Unies
Ce résultat contribue à ou aux Objectifs de développement durable suivants
-
Good health and well being
Empreinte digitale
Examiner les sujets de recherche de « Attack of the Subclones: Accurate Detection of Mutational Heterogeneity in Bulk DNA from Tumors ». Ensemble, ils forment une empreinte digitale unique.Contient cette citation
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver